<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04750889</url>
  </required_header>
  <id_info>
    <org_study_id>RFID</org_study_id>
    <nct_id>NCT04750889</nct_id>
  </id_info>
  <brief_title>Breast Localization: RFID Tags vs Wire Localization</brief_title>
  <acronym>RFID</acronym>
  <official_title>RFID Trial: Breast Localization: RFID Tags vs Wire Localization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Jean Perrin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Jean Perrin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The RFID trial focuses on breast localization in patients with non-palpable breast cancers.&#xD;
      It aims to demonstrate the improvement in patient comfort when using the Radio Frequency&#xD;
      Identification (RFID) tag and LOCalizer™ device compared to the gold standard device.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is an observational, prospective, single-center, 2-arm (RFID group vs. standard gold),&#xD;
      non-randomized and category 3 comparative study. The RFID trial focuses on breast&#xD;
      localization in patients with non-palpable breast cancers. These patients will benefit from a&#xD;
      mastology consultation: consent will then be acquired. The RFID tag or the gold standard&#xD;
      localization will be put in place during this consultation (one day before surgery).&#xD;
&#xD;
      Patients will fill in their questionnaire in two steps:&#xD;
&#xD;
        -  during the installation of the device (RFID tag or wire localization) to evaluate the&#xD;
           patient's pain,&#xD;
&#xD;
        -  then at the 1-month post-operative consultation to assess pain in the interval until&#xD;
           surgery Radiologists and surgeons will fill out the questionnaire dedicated to them&#xD;
           after each procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2021</start_date>
  <completion_date type="Anticipated">May 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the patients satisfaction</measure>
    <time_frame>1 years and 1 month</time_frame>
    <description>The value of the satisfaction score of the patient questionnaire from 0 (worst statisfaction) to 10 (better statisfaction)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction of surgeons and radiologists assessed by a questionnaire</measure>
    <time_frame>1 years and 1 month</time_frame>
    <description>overall score values from the surgeon and radiologist questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the quality of the RFID tag device by analizing surgery data</measure>
    <time_frame>1 years and 1 month</time_frame>
    <description>the occurrence or not of a migration of the RFID tag, histological data, the invasion of the margins and the rate of reoperation</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Breast Neoplasm Female</condition>
  <arm_group>
    <arm_group_label>RFID tags localization</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Wire localization</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RFID tags</intervention_name>
    <description>Installation of the RFID tag device wire localization)</description>
    <arm_group_label>RFID tags localization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wire localization</intervention_name>
    <description>Installation of the wire localization device</description>
    <arm_group_label>Wire localization</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        18 years of age or older patients requiring conservative surgical management for a breast&#xD;
        lesion infra-clinical (fibroadenomas, papillomas, atypical lesions, neoplasia), whose&#xD;
        histology will have been proven beforehand by anatomopathology&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 18 years of age or older,&#xD;
&#xD;
          -  Requiring conservative surgical management for a breast lesion -infra-clinical&#xD;
             (fibroadenomas, papillomas, atypical lesions, neoplasia), whose histology will have&#xD;
             been proven beforehand by anatomopathology.&#xD;
&#xD;
          -  Patients referred to mastology for preoperative identification by the surgeons&#xD;
&#xD;
          -  Able to give informed consent to participate in the research.&#xD;
&#xD;
          -  Affiliation to a Social Security regime&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Multiple breast lesions&#xD;
&#xD;
          -  Patients with breast neoplasia during pregnancy.&#xD;
&#xD;
          -  Person deprived of liberty or under guardianship or incapable of giving consent&#xD;
&#xD;
          -  Refusal to participate&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hugo Veyssière</last_name>
    <phone>04 73 27 80 05</phone>
    <email>hugo.veyssiere@clermont.unicancer.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Jean PERRIN</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hugo VEYSSIERE</last_name>
      <phone>0473278005</phone>
      <email>hugo.veyssiere@clermont.unicancer.fr</email>
    </contact>
    <investigator>
      <last_name>Marielle TEKATH, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 8, 2021</study_first_submitted>
  <study_first_submitted_qc>February 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>June 8, 2021</last_update_submitted>
  <last_update_submitted_qc>June 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non palpable breast cancer</keyword>
  <keyword>RFID tags</keyword>
  <keyword>Observational study</keyword>
  <keyword>Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

